Table 3.

Eligibility criteria for patients.

Patient groups	Inclusion criteria	Exclusion criteria
Patients with cancer	Cancer Receiving active treatment	Life expectancy: less than 6 months Expected need for follow-up: less than 6 months
Patients with interstitial lung disease (ILD)	ILD	Very low degree of function with risk of cognitive influence
Patients with epilepsy	Epilepsy	Complex causes of epilepsy Severe comorbidity Other planned or ongoing assessment and treatment, including assessment of unexplained illness or testing of medication
Patients with long-term, complex pain	Drug testing, adjustment, and dose reduction Self-administering medication	Comorbidity that directly affects the drug adjustment Interference with other ongoing treatment Cognitive impairment Not living at home